Literature DB >> 9732964

Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter.

J D Rich, B P Dickinson, N A Merriman, T P Flanigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9732964     DOI： 10.1111/j.1572-0241.1998.01598.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

Review 1.  Blood borne infections in sport: risks of transmission, methods of prevention, and recommendations for hepatitis B vaccination.

Authors:  R Kordi; W A Wallace
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

2.  Risk of hepatitis B and C infections in Tehranian wrestlers.

Authors:  Ramin Kordi; Keith Neal; Ali Akbar Pourfathollah; Mohammad Ali Mansournia; W Angus Wallace
Journal:  J Athl Train       Date:  2011 Jul-Aug       Impact factor: 2.860

Review 3.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

4.  Risk of hepatitis B infections in Olympic wrestling.

Authors:  S Bereket-Yücel
Journal:  Br J Sports Med       Date:  2007-03-01       Impact factor: 13.800

5.  Drug injection practices among high-risk youths: the first shot of ketamine.

Authors:  Stephen E Lankenau; Michael C Clatts
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

6.  Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Authors:  V D Hope; J McVeigh; A Marongiu; M Evans-Brown; J Smith; A Kimergård; J V Parry; F Ncube
Journal:  Epidemiol Infect       Date:  2014-04-08       Impact factor: 4.434

7.  Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.

Authors:  Vivian D Hope; Jim McVeigh; Andrea Marongiu; Michael Evans-Brown; Josie Smith; Andreas Kimergård; Sara Croxford; Caryl M Beynon; John V Parry; Mark A Bellis; Fortune Ncube
Journal:  BMJ Open       Date:  2013-09-12       Impact factor: 2.692

8.  Prevalence of sexually transmitted diseases in female athletes in São Paulo, Brazil.

Authors:  Maíta Poli de Araujo; Henrique Truffa Kleine; Tathiana Rebizzi Parmigiano; Natalia Tavares Gomes; Graziela Pascom Caparroz; Ismael Dale Cotrim Guerreiro da Silva; Manoel João Batista Castello Girão; Marair Gracio Ferreira Sartori
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.